SP02. Treatment Approaches to Tardive Dyskinesia

In this episode, Dr. Dawn Vanderhoef, PhD, DNP, PMHNP-BC, FAANP, a Board-Certified Psychiatric Mental Health Nurse Practitioner and the Associate Medical Director at Neurocrine Biosciences, in San Diego, California, talks with Dr. Kaylee Mehlman, PharmD, RPh, BCGP, FASCP, a Board-Certified Geriatric Pharmacist and Long-Term Care Clinical Practice Liaison for Neurocrine Biosciences in the Northeast. They share their insights about the recognition, diagnosis, and management of tardive dyskinesia, including its pathophysiology, clinical presentation, patient impact, and current treatment strategies.

Dr. Dawn Vanderhoef, PhD, DNP, PMHNP-BC, FAANP, is a Board-Certified Psychiatric Mental Health Nurse Practitioner and the Associate Medical Director at Neurocrine Biosciences, in San Diego, California.

Dr. Kaylee Mehlman, PharmD, RPh, BCGP, FASCP, is a Board-Certified Geriatric Pharmacist and Long-Term Care Clinical Practice Liaison for Neurocrine Biosciences in the Northeast.

This podcast is an educational program sponsored and co-developed by Neurocrine Biosciences.

Neurocrine Biosciences is a pioneering company with over 30 years of experience dedicated to discovering and developing life-changing treatments for neurological, neuroendocrine, and neuropsychiatric disorders. Learn more: https://www.neurocrine.com/

Discover GAPNA: https://www.gapna.org/

Production management by Anthony J. Jannetti, Inc., for the Gerontological Advanced Practice Nurses Association.

Opening Music by:
Optimistic / Inspirational by Mixaund | https://mixaund.bandcamp.com

Music promoted by https://www.free-stock-music.com

Closing Music by:
Scott Holmes.
http://www.scottholmesmusic.com